Dia:gram Magazine

Edition 2018 Vol. 3     Download PDF version

Cover Story

The new wave in laboratory medicine

A pathologist’s perspective



Prof. Tan Puay Hoon, Chairman, Division of Pathology and Senior Consultant, Department of Anatomical Pathology at Singapore General Hospital (SGH) enjoys the rare distinction of being the first woman from Singapore to be a volume editor of the World Health Organisation’s Classification of Tumours of the Breast. A key figure in Singapore’s anatomical pathology scene, Prof. Tan shares her views with Dia:gram on what makes pathology the foundation of medicine and the forces shaping its future.

Read the full article →


Improving cancer diagnostics for patients everywhere

Dr. Thomas Grogan pioneered the automation and standardisation of tissue biopsy testing, which has radically changed cancer detection and treatment. But his mission didn’t end there. He and his team expanded their research to the chemistry of cancer biopsies, which has enabled physicians to personalise diagnosis and treatment options for individual cancer patients. Dr. Grogan, now Founder Emeritus, gives us a glimpse into what he calls the joy of discovery and the advancements in tissue diagnostics since then.

Time to move diagnostics and medicine onto the technology curve

From commercial pilot to senior roles in consulting and banking for world-leading brands, Steve Monaghan is a well-known voice on innovation. He shares a fresh perspective on how healthcare companies can build a more inclusive future.


Heart failure in women: Taking control

Dia:gram catches up with Mrs. Sapariah Ahmat from Singapore about her experience of living with heart failure. Her particular type of heart failure - with preserved ejection fraction (HFpEF) - is increasingly the predominant form of heart failure (HF) in the developed world, and remains a challenging clinical condition to diagnose and treat1.

Ten questions with Sunil Sethi

Associate Professor Sunil Sethi took up the role of President of the Asia-Pacific Federation of Clinical Biochemistry (APFCB) in 2017. He is Senior Consultant Chemical Pathologist at the National University Hospital, Singapore; Associate Professor of Pathology at the National University of Singapore; and Group Director of the Applied Sciences Group with Singapore’s Health Sciences Authority. In this interview with Dia:gram, A/Prof. Sethi talks about his vision for the APFCB and some of his own personal passions.

Making Malaria visible

Prof. Kevin Baird, heads the Eijkman-Oxford Clinical Research Unit (EOCRU) at the Eijkman Institute of Molecular Biology in Jakarta, Indonesia on behalf of the Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom, where he is Professor of Malariology. In this interview with Dia:gram, he talks about how more needs to be done to mitigate the threat of malaria in Asia Pacific.

Predicting preeclampsia

Dr. Yi-Ning Su, is the Chairman and CEO of Sofiva Genomics Ltd and CEO of Dianthus MFM Clinic, based in Taiwan. He is a leading obstetrician and a clinical geneticist specialising in prenatal diagnosis and genetic testing. A pioneer in the field of maternal-fetal medicine, Dr. Su was the first in Taiwan to publish a paper on the correlation between preeclampsia and a protein called Placental Growth Factor, or PlGF1. This led to a new era in preeclampsia screening in Taiwan, safeguarding millions of women by accurately diagnosing their risk. In this interview with Dia:gram, Dr. Su discusses an innovative new approach for the triage of women suspected of developing this pregnancy-related complication.